Steven Lazarus's Net Worth

$598 Million

Estimate Recalculated Feb 26, 2024 09:11PM EST

Who is Steven Lazarus?

Steven Lazarus has an estimated net worth of $598 Million. This is based on reported shares across multiple companies, which include IMPINJ INC, XCYTE THERAPIES INC, AMGEN INC, XTERA COMMUNICATIONS, INC., Trubion Pharmaceuticals, Inc, CELEBRATE EXPRESS, INC., ILLUMINA INC, ALNYLAM PHARMACEUTICALS INC, NeurogesX Inc, and FIRST CONSULTING GROUP INC.

SEC CIK

Steven Lazarus's CIK is 0001054117

Past Insider Trading and Trends

2004 was Steven Lazarus's most active year for acquiring shares with 7 total transactions. Steven Lazarus's most active month to acquire stocks was the month of June. 2004 was Steven Lazarus's most active year for disposing of shares, totalling 20 transactions. Steven Lazarus's most active month to dispose stocks was the month of September. 2011 saw Steven Lazarus paying a total of $2,999,999.92 for 2,616,279 shares, this is the most they've acquired in one year. In 2003 Steven Lazarus cashed out on 330,001 shares for a total of $1,360,105.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS INC (ALNY) Snapshot price: $172.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

IMPINJ INC (PI) Snapshot price: $100.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
1.37M
$10.73
$204.50
1.37M
Jul 26
Form 4
1.36M
$11.66
$68.32
1.36M
Jul 26
Form 3
0
0
No matching records found

NeurogesX Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+71.38%
1.74M
$1.65
$2,877,906.90
4.19M
Jul 21
Form 4
+18.54%
382.17K
$6.18
$2,361,810.60
2.44M
Dec 24
Form 4
+1,015.12%
2.3M
2.53M
May 7
Form 4
227K
$11.00
$2,497,000.00
227K
May 2
Form 3
0
0
No matching records found

XCYTE THERAPIES INC (CYCC) Snapshot price: $2.29

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Oct 29
Form 4
2.05M
$8.00
$1,500,000.00
2.05M
Mar 19
Form 3/A
0
0
Form 3
0
0
No matching records found

AMGEN INC (AMGN) Snapshot price: $322.42

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.64K
1.64K
Mar 15
Form 4
-6.28%
-10.00K
$64.22
-$642,200.00
149.34K
Feb 25
Form 4
-5.91%
-10.00K
$64.01
-$640,086.56
159.34K
Feb 24
Form 4
-5.58%
-10.00K
169.34K
Nov 21
Form 4
-4.78%
-9.00K
$68.00
-$612,000.00
179.34K
Sep 8
Form 4
-0.53%
-1.00K
$68.11
-$68,105.00
188.34K
Sep 3
Form 4/A
0
189.34K
Aug 28
Form 4
-5.28%
-10.00K
$68.00
-$680,000.00
179.34K
Aug 12
No matching records found